Skip to main content
. 2023 Jun 1;11(6):1610. doi: 10.3390/biomedicines11061610

Figure 5.

Figure 5

Mechanisms of action of scFv in cancer therapy. (A) Chimeric antigen receptor (CAR) T-cells. (B) Nanoparticle-conjugate scFv. (C) Biological activity blocking. IL-2: Interleukin 2, IFN γ: Gamma Interferon, TNF-α: Tumor Necrosis Factor Alpha.